Deborah Crouch

Array ( [id] => 3763840 [patent_doc_number] => 05741957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Transgenic bovine' [patent_app_type] => 1 [patent_app_number] => 8/461333 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 50 [patent_no_of_words] => 33808 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741957.pdf [firstpage_image] =>[orig_patent_app_number] => 461333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668162 [patent_doc_number] => 07094400 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'Transkaryotic implantation' [patent_app_type] => utility [patent_app_number] => 08/465596 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14637 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094400.pdf [firstpage_image] =>[orig_patent_app_number] => 08465596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085136 [patent_doc_number] => 06054633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Live mouse mutagenesis systems for testing mutagenic agents in vivo' [patent_app_type] => 1 [patent_app_number] => 8/461607 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 33013 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054633.pdf [firstpage_image] =>[orig_patent_app_number] => 461607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4412338 [patent_doc_number] => 06300540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Transgenic mouse expressing an APP-FAD DNA sequence' [patent_app_type] => 1 [patent_app_number] => 8/464250 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 16880 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300540.pdf [firstpage_image] =>[orig_patent_app_number] => 464250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1260355 [patent_doc_number] => 06663858 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'In Vivo gene transfer using implanted retroviral producer cells' [patent_app_type] => B1 [patent_app_number] => 08/468411 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 4 [patent_no_of_words] => 9158 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/663/06663858.pdf [firstpage_image] =>[orig_patent_app_number] => 08468411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391860 [patent_doc_number] => 06537541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Implantation of HSV-TK retrovirus producer cells to destroy glioma' [patent_app_type] => B1 [patent_app_number] => 08/462500 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16840 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537541.pdf [firstpage_image] =>[orig_patent_app_number] => 08462500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245887 [patent_doc_number] => 06677311 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Inducible HSV-TK in transformed cell populations' [patent_app_type] => B1 [patent_app_number] => 08/464271 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 10799 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677311.pdf [firstpage_image] =>[orig_patent_app_number] => 08464271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939884 [patent_doc_number] => 05989849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods' [patent_app_type] => 1 [patent_app_number] => 8/461286 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 8571 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989849.pdf [firstpage_image] =>[orig_patent_app_number] => 461286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1295402 [patent_doc_number] => 06627189 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Inhibition of cellular proliferation using ras antisense molecules' [patent_app_type] => B1 [patent_app_number] => 08/459699 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 8798 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627189.pdf [firstpage_image] =>[orig_patent_app_number] => 08459699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4029967 [patent_doc_number] => 05942235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Recombinant poxvirus compositions and methods of inducing immune responses' [patent_app_type] => 1 [patent_app_number] => 8/458356 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 70953 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942235.pdf [firstpage_image] =>[orig_patent_app_number] => 458356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879584 [patent_doc_number] => 05776502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Methods of transcriptionally modulating gene expression' [patent_app_type] => 1 [patent_app_number] => 8/458691 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 50 [patent_no_of_words] => 14524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776502.pdf [firstpage_image] =>[orig_patent_app_number] => 458691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 776712 [patent_doc_number] => 06998117 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-14 [patent_title] => 'Cancer treatment with retroviral vectors comprising wild-type p53' [patent_app_type] => utility [patent_app_number] => 08/460049 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 36 [patent_no_of_words] => 21201 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998117.pdf [firstpage_image] =>[orig_patent_app_number] => 08460049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407242 [patent_doc_number] => 06265189 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen' [patent_app_type] => 1 [patent_app_number] => 8/460736 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 71329 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265189.pdf [firstpage_image] =>[orig_patent_app_number] => 460736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828784 [patent_doc_number] => 05814315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Methods for the suppression of neu mediated phenotype in tumors' [patent_app_type] => 1 [patent_app_number] => 8/457029 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 65 [patent_no_of_words] => 30834 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814315.pdf [firstpage_image] =>[orig_patent_app_number] => 457029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1149760 [patent_doc_number] => 06767535 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-27 [patent_title] => 'Suppressing tumor formation using cells expressing JE/monocyte chemoattractant protein-1' [patent_app_type] => B1 [patent_app_number] => 08/453347 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5297 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/767/06767535.pdf [firstpage_image] =>[orig_patent_app_number] => 08453347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388365 [patent_doc_number] => 06552246 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Transgenic mice comprising CD45 knockout' [patent_app_type] => B1 [patent_app_number] => 08/451318 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 16181 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552246.pdf [firstpage_image] =>[orig_patent_app_number] => 08451318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037718 [patent_doc_number] => 06872868 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-29 [patent_title] => 'Transgenic mammals' [patent_app_type] => utility [patent_app_number] => 08/449285 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5636 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872868.pdf [firstpage_image] =>[orig_patent_app_number] => 08449285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422885 [patent_doc_number] => 06515199 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Gene transfer in poultry by introduction of embryo cells in ovo' [patent_app_type] => B1 [patent_app_number] => 08/446021 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7051 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515199.pdf [firstpage_image] =>[orig_patent_app_number] => 08446021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3665310 [patent_doc_number] => 05625128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Non-human animal model of a human airway' [patent_app_type] => 1 [patent_app_number] => 8/445072 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4231 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625128.pdf [firstpage_image] =>[orig_patent_app_number] => 445072 [rel_patent_id] =>[rel_patent_doc_number] =>)